共 12 条
- [1] Phase 0 (Ph0) and Window-of-Opportunity (WoO) trial quality and reportingJOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)Khan, Omar FarooqParimi, SunilKarachiwala, HatimLin, YongtaoMonzon, Jose GerardTam, Vincent C.Chen, EricDancey, JanetTang, Patricia A.
- [2] The Future Glioblastoma Clinical Trials Landscape: Early Phase 0, Window of Opportunity, and Adaptive Phase I–III StudiesCurrent Oncology Reports, 2023, 25 : 1047 - 1055Nicholas S. ChoWeng Kee WongPhioanh L. NghiemphuTimothy F. CloughesyBenjamin M. Ellingson
- [3] The Future Glioblastoma Clinical Trials Landscape: Early Phase 0, Window of Opportunity, and Adaptive Phase I-III StudiesCURRENT ONCOLOGY REPORTS, 2023, 25 (09) : 1047 - 1055Cho, Nicholas S.Wong, Weng KeeNghiemphu, Phioanh L.Cloughesy, Timothy F.Ellingson, Benjamin M.
- [4] Phase 0 and window of opportunity clinical trial design in neuro-oncology: a RANO reviewNEURO-ONCOLOGY, 2020, 22 (11) : 1568 - 1579Vogelbaum, Michael A.Krivosheya, DariaBorghei-Razavi, HamidSanai, NaderWeller, MichaelWick, WolfgangSoffietti, RiccardoReardon, David A.Aghi, Manish K.Galanis, EvanthiaWen, Patrick Y.van den Bent, MartinChang, Susan
- [5] Sacituzumab Govitecan in patients with breast cancer brain metastases and recurrent glioblastoma: a phase 0 window-of-opportunity trialNATURE COMMUNICATIONS, 2024, 15 (01)Balinda, Henriette U.Kelly, William J.Kaklamani, Virginia G.Lathrop, Kate I.Canola, Marcela MazoGhamasaee, PegahSareddy, Gangadhara R.Michalek, JoelGilbert, Andrea R.Surapaneni, PrathibhaTiziani, StefanoPandey, RenuChiou, JenniferLodi, AlessiaFloyd, John R.Brenner, Andrew J.
- [6] A phase 0/surgical window-of-opportunity study in progress, evaluating evolocumab in patients with high-grade glioma or glioblastomaJOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (16)Singh, KiritFoster, MatthewMiller, Elizabeth S.Gregory, SimonWeinhold, Kent J.Ashley, David M.Desjardins, AnnickLow, JustinPeters, Katherine B.Severance, ErinJaggers, DeniseFriedman, Henry S.Johnson, Margaret O.Friedman, Allan H.Keir, Stephen T.Herndon, James EmmettLi, Chuan-YuanFecci, Peter E.Sampson, John H.Khasraw, Mustafa
- [7] Critical assessment of the data for Pure Cu from 0 K, using two-state model for the description of the liquid phaseCALPHAD-COMPUTER COUPLING OF PHASE DIAGRAMS AND THERMOCHEMISTRY, 2024, 84Khvan, A. V.Uspenskaya, I. A.Aristova, N. M.
- [8] Preoperative olaparib in early-stage endometrial cancer (EC): A phase 0, window of opportunity trial to evaluate the PARP inhibition effect, targeting cell cycle-related proteins (POLEN study)ANNALS OF ONCOLOGY, 2016, 27Romero, I.Rubio, M. J.Serrano, R.Medina, M.Minig, L.Casado, A.Coronado, P.Martinez, S.Orbegoso, C.Fuste, P.Guerra Alia, E. M.Sanchez-Martinez, M. C.Rubio, D.Santacana, M.Ruiz, M.Llombart-Cussac, A.Matias-Guiu, X.Poveda, A. M.
- [9] Preoperative olaparib in early-stage endometrial cancer (EC): A phase 0, window of opportunity trial to evaluate the PARP inhibition effect, targeting cell cycle-related proteins (POLEN study).JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)Romero, IgnacioRubio, M. JesusMedina, ManuelSerrano, RaquelGuerra, Eva MaSalgado, Alfonso CortesPerez, BelenMinig, LucasCasado, AntonioCoronado, PluvioFernando Cueva, JuanVilar, AnaTorne, AureliOrdi, JaumeCros, SaraSalinas, GasparSantacana, MariaAntonio Schoenenberger-Arnaiz, JuanLlombart-Cussac, AntonioPoveda, Andres
- [10] VEROnA Protocol: A Pilot, Open-Label, Single-Arm, Phase 0, Window-of-Opportunity Study of Vandetanib-Eluting Radiopaque Embolic Beads (BTG-002814) in Patients With Resectable Liver MalignanciesJMIR RESEARCH PROTOCOLS, 2019, 8 (10):Beaton, LauraTregidgo, Henry F. J.Znati, Sami A.Forsyth, SharonClarkson, Matthew J.Bandula, StevenChouhan, ManilLowe, Helen L.Thin, May ZawHague, JulianSharma, DineshPollok, Joerg-MatthiasDavidson, Brian R.Raja, JowadMunneke, GrahamStuckey, Daniel J.Bascal, Zainab A.Wilde, Paul E.Cooper, SarahRyan, SamanthaCzuczman, PeterBoucher, EvelineHartley, John A.Lewis, Andrew L.Jansen, MarnixMeyer, TimSharma, Ricky A.